title: Human serum reactivity to porcine endothelial cells after antisense-mediated down-regulation of GpIIIa expression.
abstract: The hyperacute rejection of vascularized grafts exchanged between discordant species is a result of the binding of preformed natural antibodies to the endothelium of the donor organ, and the subsequent activation of the complement system. Human natural antibodies to pig endothelial cell antigens appear to be predominantly directed at carbohydrate epitopes expressed by a variety of porcine integrins, including GpIIIa. The identification of porcine xenoantigens whose recognition by human natural antibodies results in hyperacute rejection would allow for the development of strategies to genetically modify the xenograft reaction. We have used antisense technology to down-regulate the expression of one of seven recently identified xenoantigens from the surface of pig aortic endothelial cells. Down-regulation of GpIIIa on endothelial cells resulted in a 20.8% decrease in the mean channel shift (MCS) of IgM natural antibody binding from pooled human sera, and a 28-35% decrease in the MCS of IgM binding from two high-titer individuals. The MCS for human IgG natural antibody binding to the surface of pig cells decreased by 27%. Natural antibody-mediated cytotoxicity to pig endothelial cells was not significantly altered, as indicated by a 2.5-6% decline in complement-mediated cytotoxicity. These results indicate that down-regulation of GpIIIa alone may not be sufficient to significantly alter xenograft rejection. Our results also suggest, however, that antisense-mediated regulation of a functionally important target antigen is technically feasible and may represent a strategy to prevent the xenograft reaction.
authors.affiliation: National Institute of Transplantation, St. Vincent Medical Center, Los Angeles, California 90057, USA.
authors.forename: M K
authors.initials: MK
authors.lastname: Kearns-Jonker
authors.forename: D V
authors.initials: DV
authors.lastname: Cramer
authors.forename: L A
authors.initials: LA
authors.lastname: Dane
authors.forename: J M
authors.initials: JM
authors.lastname: Swensson
authors.forename: L
authors.initials: L
authors.lastname: Makowka
mesh_terms: D000818:Animals; D016375:Antisense Elements (Genetics) / Q000494:pharmacology*; D002478:Cells, Cultured; D003001:Cloning, Molecular; D015536:Down-Regulation; D004730:Endothelium, Vascular / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007075:Immunoglobulin M / Q000276:immunology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000235:genetics / Q000502:physiology*; D011817:Rabbits; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
chemical_list: D016375:Antisense Elements (Genetics); D007074:Immunoglobulin G; D007075:Immunoglobulin M; D019039:Platelet Glycoprotein GPIIb-IIIa Complex